1
|
Hamilton SJ and Watts GF: Endothelial
dysfunction in diabetes: Pathogenesis, significance, and treatment.
Rev Diabet Stud. 10:133–156. 2013. View Article : Google Scholar
|
2
|
Winer N and Sowers JR: Epidemiology of
diabetes. J Clin Pharmacol. 44:397–405. 2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Domingueti CP, Dusse LM, Carvalho M, de
Sousa LP, Gomes KB and Fernandes AP: Diabetes mellitus: The linkage
between oxidative stress, inflammation, hypercoagulability and
vascular complications. J Diabetes Complications. 30:738–745. 2016.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Agrawal NK and Kant S: Targeting
inflammation in diabetes: Newer therapeutic options. World J
Diabetes. 5:697–710. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Westermann D, Van Linthout S, Dhayat S,
Dhayat N, Escher F, Bücker-Gärtner C, Spillmann F, Noutsias M, Riad
A, Schultheiss HP, et al: Cardioprotective and anti-inflammatory
effects of interleukin converting enzyme inhibition in experimental
diabetic cardiomyopathy. Diabetes. 56:1834–1841. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Giugliano D, Ceriello A and Paolisso G:
Diabetes mellitus, hypertension, and cardiovascular disease: Which
role for oxidative stress? Metabolism. 44:363–368. 1995. View Article : Google Scholar : PubMed/NCBI
|
7
|
Safi SZ, Batumalaie K, Qvist R, Mohd Yusof
K and Ismail IS: Gelam honey attenuates the oxidative
stress-induced inflammatory pathways in pancreatic hamster cells.
Evid Based Complement Alternat Med. 2016:58436152016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Creager MA, Lüscher TF, Cosentino F and
Beckman JA: Diabetes and vascular disease: Pathophysiology,
clinical consequences, and medical therapy: Part I. Circulation.
108:1527–1532. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Tang DD, Niu HX, Peng FF, Long HB, Liu ZR,
Zhao H and Chen YH: Hypochlorite-modified albumin upregulates
ICAM-1 expression via a MAPK-NF-κB signaling cascade: Protective
effects of apocynin. Oxid Med Cell Longev. 2016:18523402016.
View Article : Google Scholar
|
10
|
Kuo WW, Wang WJ, Tsai CY, Way CL, Hsu HH
and Chen LM: Diallyl trisufide (DATS) suppresses high
glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB
signaling via attenuating ROS generation. Int J Cardiol.
168:270–280. 2013. View Article : Google Scholar
|
11
|
Zhou J, Xu G, Ma S, Li F, Yuan M, Xu H and
Huang K: Catalpol ameliorates high-fat diet-induced insulin
resistance and adipose tissue inflammation by suppressing the JNK
and NF-κB pathways. Biochem Biophys Res Commun. 467:853–858. 2015.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Pan Y, Wang Y, Zhao Y, Peng K, Li W, Wang
Y, Zhang J, Zhou S, Liu Q, Li X, et al: Inhibition of JNK
phosphorylation by a novel curcumin analog prevents high
glucose-induced inflammation and apoptosis in cardiomyocytes and
the development of diabetic cardiomyopathy. Diabetes. 63:3497–3511.
2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu X and Sun J: Endothelial cells
dysfunction induced by silica nanoparticles through oxidative
stress via JNK/P53 and NF-kappaB pathways. Biomaterials.
31:8198–8209. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Caballo C, Palomo M, Cases A, Galán AM,
Molina P, Vera M, Bosch X, Escolar G and Diaz-Ricart M: NFκB in the
development of endothelial activation and damage in uremia: An in
vitro approach. PLoS One. 7:e433742012. View Article : Google Scholar
|
15
|
Stoltz DA, Meyerholz DK and Welsh MJ:
Origins of cystic fibrosis lung disease. N Engl J Med. 372:351–362.
2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Bérubé J, Roussel L, Nattagh L and
Rousseau S: Loss of cystic fibrosis transmembrane conductance
regulator function enhances activation of p38 and ERK MAPKs,
increasing interleukin-6 synthesis in airway epithelial cells
exposed to Pseudomonas aeruginosa. J Biol Chem. 285:22299–22307.
2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Mitola S, Sorbello V, Ponte E, Copreni E,
Mascia C, Bardessono M, Goia M, Biasi F, Conese M, Poli G, et al:
Tumor necrosis factor-alpha in airway secretions from cystic
fibrosis patients upregulate endothelial adhesion molecules and
induce airway epithelial cell apoptosis: Implications for cystic
fibrosis lung disease. Int J Immunopathol Pharmacol. 21:851–865.
2008. View Article : Google Scholar
|
18
|
Cantin AM, White TB, Cross CE, Forman HJ,
Sokol RJ and Borowitz D: Antioxidants in cystic fibrosis.
Conclusions from the CF antioxidant workshop, Bethesda, Maryland,
November 11–12, 2003. Free Radic Biol Med. 42:15–31. 2007.
View Article : Google Scholar
|
19
|
Kleme ML, Sané AT, Garofalo C and Levy E:
Targeted CFTR gene disruption with zinc-finger nucleases in human
intestinal epithelial cells induces oxidative stress and
inflammation. Int J Biochem Cell Biol. 74:84–94. 2016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Verhaeghe C, Remouchamps C, Hennuy B,
Vanderplasschen A, Chariot A, Tabruyn SP, Oury C and Bours V: Role
of IKK and ERK pathways in intrinsic inflammation of cystic
fibrosis airways. Biochem Pharmacol. 73:1982–1994. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tomaru M and Matsuoka M: The role of
mitogen-activated protein kinases in crystalline silica-induced
cyclooxygenase-2 expression in A549 human lung epithelial cells.
Toxicol Mech Methods. 21:513–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Funk SD, Yurdagul A Jr and Orr AW:
Hyperglycemia and endothelial dysfunction in atherosclerosis:
Lessons from type 1 diabetes. Int J Vasc Med.
2012:5696542012.PubMed/NCBI
|
23
|
Taye A, Saad AH, Kumar AH and Morawietz H:
Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX
1-eNOS pathway in human endothelial cells exposed to high glucose.
Eur J Pharmacol. 627:42–48. 2010. View Article : Google Scholar
|
24
|
Singh P, Khullar S, Singh M, Kaur G and
Mastana S: Diabetes to cardiovascular disease: Is depression the
potential missing link? Med Hypotheses. 84:370–378. 2015.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Prieto D, Contreras C and Sánchez A:
Endothelial dysfunction, obesity and insulin resistance. Curr Vasc
Pharmacol. 12:412–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chen J, Kinter M, Shank S, Cotton C,
Kelley TJ and Ziady AG: Dysfunction of Nrf-2 in CF epithelia leads
to excess intracellular H2O2 and inflammatory cytokine production.
PLoS One. 3:e33672008. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kelly M, Trudel S, Brouillard F, Bouillaud
F, Colas J, Nguyen-Khoa T, Ollero M, Edelman A and Fritsch J:
Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172
and GlyH-101 target mitochondrial functions, independently of
chloride channel inhibition. J Pharmacol Exp Ther. 333:60–69. 2010.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Norkina O, Burnett TG and De Lisle RC:
Bacterial overgrowth in the cystic fibrosis transmembrane
conductance regulator null mouse small intestine. Infect Immun.
72:6040–6049. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Dong ZW, Chen J, Ruan YC, Zhou T, Chen Y,
Chen Y, Tsang LL, Chan HC and Peng YZ: CFTR-regulated MAPK/NF-κB
signaling in pulmonary inflammation in thermal inhalation injury.
Sci Rep. 5:159462015. View Article : Google Scholar
|
30
|
Chen J, Jiang XH, Chen H, Guo JH, Tsang
LL, Yu MK, Xu WM and Chan HC: CFTR negatively regulates
cyclooxygenase-2-PGE(2) positive feedback loop in inflammation. J
Cell Physiol. 227:2759–2766. 2012. View Article : Google Scholar
|
31
|
Mitchell S, Vargas J and Hoffmann A:
Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med.
8:227–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Kaneto H, Nakatani Y, Kawamori D,
Miyatsuka T and Matsuoka TA: Involvement of oxidative stress and
the JNK pathway in glucose toxicity. Rev Diabet Stud. 1:165–174.
2004. View Article : Google Scholar
|
33
|
Roque T, Boncoeur E, Saint-Criq V, Bonvin
E, Clement A, Tabary O and Jacquot J: Proinflammatory effect of
sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane
conductance regulator lung epithelial cells: Involvement of
extracellular signal-regulated protein kinase 1/2 and
c-Jun-NH2-terminal kinase signaling. J Pharmacol Exp Ther.
326:949–956. 2008. View Article : Google Scholar : PubMed/NCBI
|